CHRNA7 and Parkinson disease: Liu et al. demonstrated that activation of astroglial α7 nAChRs may provide protection against degeneration of dopaminergic neurons by inhibition of MPTP (in vivo)- and MPP+- or LPS (in vitro)-induced astrogliosis in Parkinson’s disease [12].